Abstract
A female patient with tyrosinaemia type II is reported having undergone two untreated pregnancies. During pregnancies, plasma tyrosine was raised. The outcomes of both offspring show that maternal tyrosinaemia may have an adverse effect on the developing fetus.
Similar content being viewed by others
REFERENCES
Fois A, Borgogni P, Cioni M, et al (1986) Presentation of the data of the Italian Registry of Oculocutaneous Tyrosinaemia. J Inherit Metab Dis 9(supplement 2): 262-264.
Francis DEM, Kirby DM, Thompson GN (1992) Maternal tyrosinaemia II: management and successful outcome. Eur J Pediatr 151: 196-199.
Garibaldi LR, Siliato F, de Martini I, et al (1977) Oculocutaneous tyrosinosis: report of two cases in the same family. Helv Paediatr Acta 32: 173-180.
Hyanek J, Homolka J, Trnka J, et al (1979) Results of screening for phenylalanine and other amino acid disturbances among pregnant women. J Inherit Metab Dis 2: 59-63.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cerone, R., Fantasia, A.R., Castellano, E. et al. Pregnancy and tyrosinaemia type II. J Inherit Metab Dis 25, 317–318 (2002). https://doi.org/10.1023/A:1016558510123
Issue Date:
DOI: https://doi.org/10.1023/A:1016558510123